US drugmaker Pfizer posted blockbuster earnings that far exceed market expectations.
The company's COVID-19 vaccine accounted for nearly a quarter of revenues which came in at $14.6 billion dollars.
From New York, US correspondent Liling Tan breaks down the numbers.
IN: "Three-point-five…
OUT: SOC
DUR: 39 seconds
All: http://www.fsnradionews.com/feeds/0504-PfizerEarnings-lt-generic.mp3